Lokman Hekim Engurusag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhut A.S.

Lokman Hekim Engurusag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhut A.S.

BBIST:LKMNH
10.93
TRY
-0.10
(-0.91%)
0.70EPS
28.53P/E
3.37BMarket Cap
Nov 12Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.5
0.58
0.66
0.9
1.14
1.32
1.55
1.47
2.1
7.68
12.67
17.83
19.6
22.5
Basic EPS, GAAP
0.01
0.01
0.02
0.03
0.03
0.04
0.04
0.11
0.33
1.47
2.15
1.45
0.7
0.55
Free Cash Flow per Basic Share
3.71
-0.03
0.01
-0.12
-0.12
-0.22
-0.04
0.07
-0.07
-0.52
1.1
-0.34
-3.27
-0.99
Dividend per Share
- -
- -
0.01
- -
- -
- -
- -
- -
- -
0.16
0.39
0.26
0.55
1.37
Book Value per Share
0.28
0.28
0.29
0.31
0.3
0.32
0.36
0.52
0.84
4.58
8.31
11.55
10.95
12.72
Tangible Book Value per Share
0.23
0.23
0.25
0.18
0.17
0.19
0.24
0.4
0.74
3.82
6.9
9.69
8.79
10.08
Basic Weighted Avg Shares
216
216
216
216
216
216
216
216
216
216
216
216
216
216
Sales/Revenue/Turnover
107
126
142
194
246
286
335
317
453
1,659
2,737
3,850
4,234
4,860
Operating Margin (%)
1.68
4.95
6.96
9.89
6.74
8.5
6.17
15.61
17.28
7.82
9.08
9.2
9.36
11.17
Depreciation Expense
- -
- -
8
7
9
9
18
19
25
206
342
497
508
531
Net Income, GAAP
1
2
5
7
6
8
8
24
70
317
465
314
150
118
Effective Tax Rate (%)
- -
12
- -
- -
- -
0.37
- -
18.26
- -
- -
- -
32.16
45.25
54.14
Profit Margin (%)
1.07
1.35
3.79
3.54
2.56
2.92
2.47
7.66
15.49
19.11
17
8.15
3.55
2.43
Working Capital
-14
-1
10
3
- -
-42
-31
-38
-40
-127
-80
-4
-601
-621
LT Debt
5
14
17
27
43
36
109
100
73
308
265
484
489
671
Total Equity
60
61
67
76
78
84
94
130
221
1,086
1,917
2,717
2,595
3,022
Return on Invested Capital (%)
- -
5.55
- -
- -
- -
13.6
- -
13.51
- -
- -
- -
8.73
6.18
7.5
Return on Capital (%)
- -
6.1
- -
- -
- -
12.44
- -
11.53
- -
- -
- -
14.2
4.04
3.54
Return on Common Equity (%)
2.32
2.85
8.79
11.02
10.22
13.43
12.2
27.78
49.25
54.07
33.39
14.63
6.19
4.76

Capital Structure

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2,025
2,217
2,028
LT Borrowings
399
521
554
LT Finance Leases
90
78
117
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
216
216
216
Market Capitalization
4,145
3,262
3,365

Working Capital

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,040
2,643
2,671
Cash, Cash Equivalents & STI
249
418
50
Accounts Receivable, Net
752
955
1,201
Inventories
361
406
409
Total Current Liabilities
2,641
3,199
3,292
Payables & Accruals
- -
- -
- -
ST Debt
2,025
2,217
2,028
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
64.9%
114.97%
-4.47%
Free Cash Flow
-31.94%
180.23%
863.87%
Net Income, GAAP
74.79%
100.61%
-52.1%
Sales/Revenue/Turnover
51.64%
84.92%
9.97%
Total Cash Common Dividend
- -
- -
110.84%

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
853
798
943
861
3,850
2025
1,142
1,155
1,021
1,278
4,234
2026
1,275
1,286
- -
- -
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.48
0.22
0.06
0.48
1.45
2025
0.15
0.36
0.14
0.14
0.7
2026
0.1
0.17
- -
- -
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.18
-0.07
0.26
2025
0.13
- -
- -
0.06
0.55
2026
0.41
0.9
- -
- -
- -

Company Description

CEO
Mustafa Sarioglu
Full Time Employees
2,426
Sector
Health services
Industry
Medical/Nursing services
Address
Ankara Turkey
IPO Date
Feb 1, 2011
Business
Lokman Hekim Engurusag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhut A.S. is a Turkey-based healthcare services company primarily engaged in the ownership and operation of general and specialized hospitals, outpatient medical centers, diagnostic laboratories, and health tourism facilities. Founded in 1996 and headquartered in Ankara, Turkey, the company delivers comprehensive inpatient, outpatient, surgical, and emergency medical services across domestic and international markets. The company operates across core business segments comprising Healthcare Services, Medical Tourism, Educational and Academic Collaborations, and Healthcare Construction and Facility Contracting. The company provides an extensive portfolio of medical, diagnostic, and surgical services structured across specialized clinical departments, including: cardiovascular surgery, adult cardiology, and interventional cardiology; medical oncology, radiation oncology, and chemotherapy management; obstetrics, gynecology, and neonatal intensive care; orthopedics, traumatology, and joint replacement surgery; brain, nerve, and spinal surgery (neurosurgery) alongside neurology; general surgery, bariatric surgery, and laparoscopic procedures; urology, nephrology, and hemodialysis units; ophthalmology and eye surgery; otorhinolaryngology; internal medicine, endocrinology, gastroenterology, and endoscopy; pediatric medicine and pediatric surgery; physical therapy, rehabilitation, and sports medicine; oral and dental health; plastic, reconstructive, and aesthetic surgery; emergency care, adult intensive care, coronary intensive care, and 24/7 ambulance services; and clinical biochemistry, microbiology, pathology, and advanced diagnostic imaging comprising magnetic resonance imaging (MRI), computed tomography (CT), digital mammography, ultrasonography, and X-ray diagnostics. In addition to primary medical care, the company offers specialized health tourism services featuring international patient reception, translation assistance, medical travel planning, and accommodation coordination, while also engaging in medical infrastructure construction and hospital equipment procurement. In recent developments, Lokman Hekim Engurusag Saglik has focused on network modernization, clinical capacity expansion, and the scaling of its international health tourism operations. The company has carried out infrastructure upgrades, bed capacity expansions, and medical technology enhancements across its flagship facilities, including Lokman Hekim Ankara Hospital, Lokman Hekim Akay Hospital, Lokman Hekim Istanbul Hospital, and regional hospital campuses in Van. To capture rising international demand, the company has expanded its overseas patient coordination network and marketing representations targeting the Middle East, Central Asia, and Europe. Furthermore, the company has deepened its academic and clinical integration with Lokman Hekim University to advance tertiary clinical research, residency training, and specialized treatment protocols, alongside implementing corporate sustainability programs, healthcare facility energy-efficiency investments, and capital management initiatives to support long-term operational growth.